Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-6.84 Insider Own13.60% Shs Outstand81.12M Perf Week11.80%
Market Cap3.36B Forward P/E- EPS next Y-6.72 Insider Trans4.28% Shs Float76.29M Perf Month11.34%
Income-517.18M PEG- EPS next Q-1.81 Inst Own84.19% Short Float12.91% Perf Quarter-28.79%
Sales0.00M P/S- EPS this Y-31.49% Inst Trans334.24% Short Ratio6.99 Perf Half Y-18.09%
Book/sh3.68 P/B10.34 EPS next Y10.77% ROA-99.74% Short Interest9.85M Perf Year52.36%
Cash/sh3.23 P/C11.79 EPS next 5Y- ROE-133.69% 52W Range16.45 - 62.21 Perf YTD-11.00%
Dividend Est.- P/FCF- EPS past 5Y- ROI-157.42% 52W High-38.77% Beta4.13
Dividend TTM- Quick Ratio4.03 Sales past 5Y0.00% Gross Margin- 52W Low131.55% ATR (14)1.70
Dividend Ex-Date- Current Ratio4.03 EPS Y/Y TTM16.13% Oper. Margin0.00% RSI (14)63.40 Volatility3.50% 3.96%
Employees239 Debt/Eq0.10 Sales Y/Y TTM- Profit Margin- Recom1.09 Target Price57.89
Option/ShortYes / Yes LT Debt/Eq0.09 EPS Q/Q-112.85% Payout- Rel Volume0.70 Prev Close37.95
Sales Surprise- EPS Surprise-42.07% Sales Q/Q- EarningsMay 09 AMC Avg Volume1.41M Price38.09
SMA2010.48% SMA505.60% SMA200-3.11% Trades Volume983,221 Change0.37%
Date Action Analyst Rating Change Price Target Change
Feb-16-24Initiated RBC Capital Mkts Outperform $62
Feb-06-24Initiated UBS Buy $59
Dec-22-23Initiated H.C. Wainwright Buy $50
Dec-08-23Initiated Robert W. Baird Outperform $58
Jan-24-23Initiated SVB Securities Outperform $24
Jan-04-23Initiated JP Morgan Overweight $23
Dec-02-22Initiated BTIG Research Buy $24
Oct-26-22Upgrade Cantor Fitzgerald Neutral → Overweight $158 → $27
Oct-12-22Initiated Piper Sandler Overweight $23
Aug-19-22Downgrade Piper Sandler Overweight → Neutral $149
Jul-01-24 07:00AM
Jun-28-24 10:00AM
May-29-24 07:30AM
May-15-24 11:00AM
09:35AM Loading…
May-14-24 09:35AM
May-13-24 09:35AM
May-09-24 11:54PM
May-01-24 02:38PM
Apr-26-24 06:00AM
Apr-25-24 11:00AM
Apr-23-24 11:00AM
Apr-22-24 04:05PM
Apr-18-24 06:00AM
04:05PM Loading…
Apr-17-24 04:05PM
Apr-13-24 09:00AM
Apr-03-24 10:03PM
Feb-29-24 04:05PM
Jan-25-24 05:31PM
Jan-22-24 07:00AM
Jan-08-24 07:30AM
Jan-02-24 07:00AM
Dec-31-23 03:01AM
Dec-01-23 04:30PM
Nov-16-23 09:40AM
Nov-14-23 09:15PM
Nov-06-23 08:50AM
Oct-31-23 09:40AM
08:50AM Loading…
Oct-19-23 08:50AM
Oct-16-23 07:00AM
Oct-06-23 01:01PM
Oct-05-23 04:05PM
Oct-03-23 08:50AM
Oct-02-23 11:56PM
Sep-29-23 10:00AM
Sep-28-23 07:53AM
Sep-27-23 04:09PM
Sep-14-23 07:00AM
Sep-05-23 07:00AM
Aug-09-23 06:01AM
Jul-31-23 09:31AM
Jul-27-23 12:50PM
Jun-27-23 05:31AM
Jun-02-23 09:11AM
Jun-01-23 04:08PM
May-31-23 07:00AM
May-25-23 05:00PM
May-24-23 01:30PM
May-12-23 04:30PM
May-05-23 10:43AM
Apr-17-23 07:00AM
Mar-30-23 09:40AM
Mar-25-23 09:22AM
Mar-23-23 04:05PM
Mar-22-23 07:30AM
Mar-14-23 07:30AM
Mar-13-23 11:39AM
Feb-23-23 08:36AM
Feb-21-23 07:30AM
Feb-10-23 02:55PM
Feb-02-23 12:52PM
Jan-06-23 07:58AM
Jan-05-23 09:40AM
Dec-23-22 06:21AM
Nov-29-22 09:35AM
Nov-28-22 09:55AM
Nov-21-22 09:33AM
Nov-09-22 08:35AM
Nov-08-22 11:52AM
Nov-06-22 11:48AM
Nov-01-22 10:01AM
Oct-25-22 08:21PM
Oct-20-22 10:30PM
Oct-18-22 04:12PM
Oct-07-22 03:24AM
Oct-06-22 10:54AM
Oct-05-22 04:45PM
Oct-04-22 12:29PM
Oct-03-22 01:01PM
Sep-30-22 04:09PM
Sep-29-22 04:09PM
Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Car BruceChief Scientific OfficerJun 17 '24Buy33.5830,0001,007,49030,000Jun 20 07:30 AM
CHILDS JOHN WDirectorMay 30 '24Buy35.5828,000996,2402,311,341May 31 09:04 AM
CHILDS JOHN WDirectorMay 13 '24Buy35.1728,5001,002,4702,283,341May 14 07:30 AM
Bailey GregoryDirectorMay 13 '24Buy34.1915,000512,8771,615,071May 15 07:31 AM
Bailey GregoryDirectorApr 24 '24Buy39.1825,503999,1691,600,071Apr 25 07:32 AM
CHILDS JOHN WDirectorApr 22 '24Buy41.00195,1217,999,9614,096,512Apr 23 07:54 AM
Coric VladChief Executive OfficerApr 22 '24Buy41.00121,9514,999,9911,788,417Apr 23 07:54 AM
Bailey GregoryDirectorApr 22 '24Buy41.0048,7801,999,9801,574,568Apr 23 07:54 AM
Antonijevic IrinaDirectorDec 29 '23Option Exercise0.0011,000013,535Dec 29 06:25 PM
Antonijevic IrinaDirectorDec 29 '23Sale41.7911,000459,6622,535Dec 29 06:25 PM
CHILDS JOHN WDirectorOct 05 '23Buy22.00454,5459,999,9903,998,952Oct 10 07:07 PM
Coric VladChief Executive OfficerOct 05 '23Buy22.00340,9087,499,976833,120Oct 10 07:17 AM
Coric VladChief Executive OfficerOct 05 '23Buy22.00113,6372,500,0141,657,031Oct 10 07:17 AM
Buten MatthewChief Financial OfficerOct 05 '23Buy22.0022,727499,994189,380Oct 06 07:38 AM
Bailey GregoryDirectorOct 04 '23Buy22.5717,817402,0941,525,788Oct 06 07:37 AM
CHILDS JOHN WDirectorAug 30 '23Buy18.4450,000922,1801,975,118Aug 31 08:56 AM
CHILDS JOHN WDirectorAug 04 '23Buy19.78100,0001,978,4301,925,118Aug 07 07:29 AM